Mid-cap biotechs join Trump’s latest round of drug pricing deals
In a significant development for the U.S. pharmaceutical landscape, the Trump administration on Monday announced...
Knowledge and News for the Global Fight Against Cancer.
In a significant development for the U.S. pharmaceutical landscape, the Trump administration on Monday announced...
The onset of September marks the beginning of Childhood Cancer Awareness Month, a global initiative...
Eli Lilly and Company, a global pharmaceutical giant, announced on August 31, 2026, its strategic...
Sarcoma, a notably rare and intricate group of cancers, presents unique challenges in diagnosis and...
The burgeoning field of cell therapy for autoimmune diseases has hit a significant roadblock, as...
The medical journey of Lauren Kate, a nine-year-old girl from Tennessee, has become a poignant...
The Maddy Nelson Memorial Foundation recently concluded its second annual Walk by Faith Gala in...
CureSearch for Children’s Cancer, a national non-profit organization dedicated to ending childhood cancer by driving...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg),...
The U.S. Food and Drug Administration (FDA) has granted clearance for Mimrylo, Takeda Pharmaceutical Company’s...